NALTREXONE -50MG -100CT - Multiple CMOPs - 770-25-3-801-0426

The Department of Veterans Affairs Veterans Health Administration (VA) has issued a Request for Quote (RFQ) No. 36C77025Q0114 seeking Naltrexone 50mg tablets for distribution to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations. The solicitation requires pharmaceutical suppliers to provide 10,380 bottles of medication across seven line items, with specific requirements including therapeutic equivalence code "A", bar code labeling, and a minimum 12-month expiration date. Vendors must comply with the Drug Supply Chain Security Act and operate within the pharmaceutical manufacturing sector (NAICS 325412). The RFQ is due by May 13, 2025, at 4:00 PM CDT, with submissions open to all qualified vendors. Evaluation criteria appear to focus on meeting precise pharmaceutical specifications and delivery requirements to VA healthcare facilities.

This solicitation is an unrestricted procurement with potential opportunities for small business participation, targeting pharmaceutical suppliers with up to 1,300 employees. The medication will be distributed to CMOP locations in Leavenworth, Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Charleston, covering a nationwide delivery network. While specific award values are not explicitly stated in the available documents, the procurement involves a significant volume of 10,380 bottles of Naltrexone medication. The contract falls under Product Service Code 6505 for Drugs and Biologicals, indicating a specialized pharmaceutical supply requirement. Performance will occur throughout the United States, with the VA Veterans Integrated Service Network 15 managing the procurement process and subsequent distribution of the pharmaceutical product.